Dabrafenib; Preclinical Characterization, Increased Efficacy when Combined with Trametinib, while BRAF/MEK Tool Combination Reduced Skin Lesions.
| Autor: | King, Alastair J.1, Arnone, Marc R.1, Bleam, Maureen R.1, Moss, Katherine G.1, Yang, Jingsong2, Fedorowicz, Kelly E.2, Smitheman, Kimberly N.1, Erhardt, Joseph A.3, Hughes-Earle, Angela4, Kane-Carson, Laurie S.5, Sinnamon, Robert H.6, Qi, Hongwei6, Rheault, Tara R.7, Uehling, David E.7, Laquerre, Sylvie G.1 sylvie.g.laquerre@gsk.com |
|---|---|
| Zdroj: | PLoS ONE. Jul2013, Vol. 8 Issue 7, p1-10. 10p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|